Presentation Information

[O01-08]Long-term impacts of filgotinib on bowel and systemic symptoms in patients with ulcerative colitis: a post hoc analysis of the SELECTION and SELECTION long-term extension trials

*Fumihito Hirai1, Stefan Schreiber2, Armando Lunello3, Chisa Nagakura4, Toshihiko Kaise4, Toshifumi Hibi5 (1. Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, 2. Department Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany, 3. Alfasigma S.p.A., Milan, Italy, 4. Gilead Sciences K.K., Tokyo, Japan, 5. Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Comment

To browse or post comments, you must log in.Log in